An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma

Abstract EN

Cholangiocarcinoma (CCA) is an aggressive biliary tract malignancy arising from the epithelial bile duct.

The lack of early diagnostic biomarkers as well as therapeutic measures results in severe outcomes and poor prognosis.

Thus, effective early diagnostic, prognostic, and therapeutic biomarkers are required to improve the prognosis and prolong survival rates in CCA patients.

Recent advancement in omics technologies combined with the integrative experimental and clinical validations has provided an insight into the underlying mechanism of CCA initiation and progression as well as clues towards novel biomarkers.

This work highlights the discovery and validation of molecular markers in CCA identified through omics approaches.

The possible roles of these molecules in various cellular pathways, which render CCA carcinogenesis and progression, will also be discussed.

This paper can serve as a reference point for further investigations to yield deeper understanding in the complex feature of this disease, potentially leading to better approaches for diagnosis, prognosis, and therapeutics.